117 related articles for article (PubMed ID: 35380751)
1. Cervical Cancer Screening in a Human Immunodeficiency Virus Treatment Centre in Zaria North-Western Nigeria.
Yahya A; Mustapha A; Kolawole AOD; Oguntayo AO; Lawal BK
West Afr J Med; 2022 Mar; 39(3):291-298. PubMed ID: 35380751
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus seroprevalence in patients with invasive cervical cancer in Zaria, North-Western Nigeria.
Abdullahi A; Mustapha MI; David DA; Ayodeji OT
Ann Afr Med; 2018; 17(1):17-21. PubMed ID: 29363631
[TBL] [Abstract][Full Text] [Related]
3. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context.
Adedimeji A; Ajeh R; Pierz A; Nkeng R; Ndenkeh JJ; Fuhngwa N; Nsame D; Nji M; Dzudie A; Anastos KM; Castle PE
BMC Womens Health; 2021 Feb; 21(1):74. PubMed ID: 33602194
[TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.
Kimondo FC; Kajoka HD; Mwantake MR; Amour C; Mboya IB
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1374. PubMed ID: 33739611
[TBL] [Abstract][Full Text] [Related]
5. An unmet cancer screening need of HIV-positive women in southeastern Nigeria.
Dim CC; Dim NR; Ezegwui HU; Ikeme AC
Medscape J Med; 2009; 11(1):19. PubMed ID: 19295940
[TBL] [Abstract][Full Text] [Related]
6. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
Mengesha MB; Chekole TT; Hidru HD
BMC Womens Health; 2023 Jun; 23(1):338. PubMed ID: 37370091
[TBL] [Abstract][Full Text] [Related]
7. Awareness, Knowledge and Attitudes Towards Cervical Cancer Amongst HIV-Positive Women Receiving Care in a Tertiary Hospital in Nigeria.
Adibe MO; Aluh DO
J Cancer Educ; 2018 Dec; 33(6):1189-1194. PubMed ID: 28477269
[TBL] [Abstract][Full Text] [Related]
8. Experiences of cervical cancer screening in HIV-positive women in Zimbabwe.
Mpata PC; Nkosi ZZ
Curationis; 2021 Nov; 44(1):e1-e7. PubMed ID: 34797107
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
10. Awareness, Knowledge and Attitude Regarding Cervical Cancer among Women Living with HIV in the Souss-Massa Region, Southern Morocco: A Cross-Sectional Study.
Arechkik A; Lahlou L; Kharbach A; Baba MA; Obtel M; Razine R
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2875-2884. PubMed ID: 37642077
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
Ninsiima M; Nyabigambo A; Kagaayi J
BMC Health Serv Res; 2023 Apr; 23(1):333. PubMed ID: 37013535
[TBL] [Abstract][Full Text] [Related]
12. Utilization of opportunistic cervical cancer screening in Nigeria.
Habila MA; Sagay E; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
Cancer Causes Control; 2024 Jan; 35(1):9-20. PubMed ID: 37530986
[TBL] [Abstract][Full Text] [Related]
13. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment.
New-Aaron M; Meza JL; Goedert MH; Kibusi SM; Mkhoi ML; Mayengo CD; Charles J; Shabani S; Musil KM; Cheney A; Sumba S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2035-2045. PubMed ID: 32711430
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study.
Sarah Maria N; Olwit C; Kaggwa MM; Nabirye RC; Ngabirano TD
BMC Womens Health; 2022 May; 22(1):148. PubMed ID: 35538482
[TBL] [Abstract][Full Text] [Related]
15. Motivations and barriers to cervical cancer screening among HIV infected women in HIV care: a qualitative study.
Bukirwa A; Mutyoba JN; Mukasa BN; Karamagi Y; Odiit M; Kawuma E; Wanyenze RK
BMC Womens Health; 2015 Oct; 15():82. PubMed ID: 26458898
[TBL] [Abstract][Full Text] [Related]
16. Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It?
Rosser JI; Njoroge B; Huchko MJ
J Cancer Educ; 2016 Jun; 31(2):413-8. PubMed ID: 25982550
[TBL] [Abstract][Full Text] [Related]
17. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria.
Habila MA; Obeng-Kusi M; Ali MJ; Magaji FA; Shambe IH; Daru PH; Jacobs ET; Madhivanan P; Sagay AS; Musa J
BMC Womens Health; 2023 Nov; 23(1):640. PubMed ID: 38037005
[TBL] [Abstract][Full Text] [Related]
18. Barriers to Cervical Cancer Screening Among Women Living With HIV in Low- and Middle-Income Countries: A Systematic Review.
Guillaume D; Chandler R; Igbinoba S
J Assoc Nurses AIDS Care; 2020; 31(5):497-516. PubMed ID: 32675646
[TBL] [Abstract][Full Text] [Related]
19. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.
Wanyenze RK; Bwanika JB; Beyeza-Kashesya J; Mugerwa S; Arinaitwe J; Matovu JKB; Gwokyalya V; Kasozi D; Bukenya J; Makumbi F
Glob Health Action; 2017; 10(1):1380361. PubMed ID: 29035163
[TBL] [Abstract][Full Text] [Related]
20. Awareness, perception and factors affecting utilization of cervical cancer screening services among women in Ibadan, Nigeria: a qualitative study.
Ndikom CM; Ofi BA
Reprod Health; 2012 Aug; 9():11. PubMed ID: 22866676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
